secwatch.observer — SEC 8-K summary
======================================

Issuer:     ABVC BIOPHARMA, INC. (ABVC)
CIK:        0001173313
Form:       8-K
Filed at:   2025-10-30T23:59:59+00:00
Accession:  0001213900-25-103799
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ABVC BioPharma approves performance incentive plan contingent on $1B market cap by Dec 31, 2027
--------------------------------------------------------------------------------

- Plan grants up to 1% of outstanding shares, capped at $10M total and $1M per recipient.
- Effective only if ABVC maintains $1B market cap for 30 consecutive trading days before 2027 deadline.
- Shares come from Amended 2016 Equity Incentive Plan; allocation set by Compensation Committee and Board.
- No guarantee the condition will be met; plan may never be implemented.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025103799/0001213900-25-103799-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1173313/000121390025103799/ea0262960-8k_abvcbio.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-103799

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer